Uses of the drug Sumocolat

With effective mucolytic effect, Xumocolat drug is used in cases of respiratory diseases such as acute and chronic bronchitis, rhinitis and sinusitis.

1.1. What is Sumocolat? Xumocolat belongs to the group of drugs acting on the respiratory tract, with registration number VD-16244-12, produced by Ha Tay Pharmaceutical Joint Stock Company.
Xumocolat drug includes the following ingredients:
Main active ingredient: Acetylcysteine ​​200mg. Excipients include: Lactose, aspartame, colloidal silicon dioxide, orange flavor powder. Xumocolat is made in the form of a 200mg powder for oral suspension, 2g pack, 30 sachets and is recommended for use by children 2 years of age or older or adults.
1.2. What diseases does Sumocolat treat? Active ingredient Acetylcysteine ​​is used as a mucolytic drug, detoxifying when overdose of paracetamol. The drug reduces the consistency of purulent or non-purulent sputum and facilitates expulsion of sputum by cough, orthostatic drainage, or by mechanical means.
Xumocolat is used to treat the following cases:
Mucoviscidosis, respiratory diseases with sputum and mucus such as acute and chronic bronchitis, rhinitis, laryngitis, Sinusitis, otitis media with discharge and mucus clearance in case of bronchiectasis. Used as an antidote in paracetamol overdose. Contraindications of Xumocolat:
Patients who are allergic to the main ingredient Acetylcysteine ​​or any of the listed excipients of the drug Xumocolat. History of asthma (risk of bronchospasm with all forms of acetylcysteine). Children under 2 years old.

2.1. How to take Xumocolat medicine Xumocolat is taken orally. Mix the package of Xumocolat in about 50ml of filtered water, let it dissolve completely, and then drink it. Do not mix Xumocolat with other mixtures. Follow the exact dose prescribed by your doctor. 2.2. Dosage of medicine Xumocolat Mucolytic:
Adults & children > 14 years old: 1 pack x 2-3 times/day. Children 6-14 years old: 1 pack x 2 times/day or half a pack x 3 times/day. Children 2 - 5 years old: Half a pack x 2-3 times/day. Increased mucus secretion:
Children > 6 years old: 1 pack x 3 times/day. Children 2 - 5 years old: Half a pack x 4 times/day. Handling missed dose:
Take the dose as soon as you remember. Skip the missed dose if it is almost time for your next dose, take your next dose as scheduled. Do not take twice the dose of Xumocolat indicated. Treatment of overdose:
Overdosing with Xumocolat has symptoms similar to those of anaphylaxis, but much more severe, especially a drop in blood pressure. Other symptoms include respiratory failure, hemolysis, disseminated intravascular coagulation, and renal failure. An overdose of acetylcysteine ​​occurs when the infusion is too rapid and in high doses.

Patients at risk of asthma must be closely monitored, if acetylcysteine ​​​​is used in people with a history of allergies. If bronchospasm is present, a bronchodilator nebulizer such as salbutamol (a selective, short-acting beta-2 adrenergic agent) or ipratropium (an antimuscarinic agent) must be used and acetylcysteine ​​should be discontinued immediately. During treatment with acetylcysteine, a large amount of thin sputum may appear in the bronchi, which must be aspirated to remove if the patient's ability to cough is reduced.

At therapeutic doses, Xumocolat was well tolerated. However, during the use of Xumocolat, patients may still experience side effects such as:
Common: Nausea and vomiting. Uncommon: Drowsiness, headache, tinnitus, stomatitis, rhinorrhea, rash and urticaria. Rare: Bronchospasm with systemic anaphylactoid reactions, fever and chills. Treatment:
Using diluted acetylcysteine ​​solution can reduce the possibility of drug-induced vomiting. Anaphylactoid reactions must be treated immediately with subcutaneous adrenaline injection (0.3 - 0.5 ml of 1/1000 solution) 100% oxygen, intubation if necessary, intravenous fluids to increase plasma volume. , inhaled beta-adrenergic agonist if bronchospasm, intravenous 500 mg hydrocortisone or 125 mg methylprednisolone. Hypersensitivity reactions to acetylcysteine, including generalized erythema, pruritus, nausea, vomiting, and dizziness, can be inhibited by pre-administration of antihistamines. It has been suggested that hypersensitivity is due to a pseudoallergic mechanism based on histamine release rather than immunological etiology. Because hypersensitivity reactions have occurred in up to 3% of people who received intravenous acetylcysteine ​​​​to treat paracetamol overdose, physicians should pay attention to using antihistamines to prevent such reactions.

Acetylcysteine ​​is a reducing agent so it is not suitable for oxidizing agents. Do not use concurrently with other cough medicines or any drugs that reduce bronchial secretion during treatment with acetylcysteine.

The shelf life of Xumocolat is 24 months from the date of manufacture. Store Sumocolat in a cool, dry place, at a temperature not exceeding 30°C, in its original packaging and protected from light. Keep Sumocolat out of reach of children. Above is all information about the drug Xumocolat, patients need to carefully read the instructions for use, consult a doctor / pharmacist before using. Absolutely do not arbitrarily buy Xumocolat for home treatment because there may be unwanted side effects.